US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist
  • 0.635
  • -0.015-2.25%
Close Dec 20 16:00 ET
  • 0.648
  • +0.013+2.09%
Post 20:01 ET
80.13MMarket Cap-0.60P/E (TTM)

Karyopharm Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-35.90%133.53M
-35.75%152.12M
-42.94%148.58M
-31.13%191.44M
-31.13%191.44M
40.39%208.32M
38.58%236.77M
26.82%260.38M
21.59%277.97M
21.59%277.97M
-Cash and cash equivalents
66.83%72.83M
4.80%84.77M
-63.56%30.63M
-61.36%52.23M
-61.36%52.23M
-38.82%43.66M
-1.65%80.89M
-45.15%84.06M
-29.02%135.19M
-29.02%135.19M
-Short-term investments
-63.14%60.7M
-56.79%67.35M
-33.11%117.95M
-2.50%139.21M
-2.50%139.21M
113.76%164.66M
75.93%155.87M
238.72%176.32M
274.20%142.78M
274.20%142.78M
Receivables
-16.20%31.78M
17.70%38M
-11.70%31.08M
-42.74%26.96M
-42.74%26.96M
38.17%37.92M
37.48%32.28M
40.85%35.2M
109.30%47.09M
109.30%47.09M
-Accounts receivable
-16.20%31.78M
17.70%38M
-11.70%31.08M
-42.74%26.96M
-42.74%26.96M
38.17%37.92M
37.48%32.28M
40.85%35.2M
109.30%47.09M
109.30%47.09M
Inventory
50.47%4.67M
-5.34%3.48M
-27.65%2.77M
-27.96%3.04M
-27.96%3.04M
-26.92%3.11M
5.82%3.67M
-1.21%3.83M
2.87%4.22M
2.87%4.22M
Restricted cash
-93.94%33K
-94.36%32K
-45.74%459K
-37.97%660K
-37.97%660K
-49.54%545K
-50.52%567K
-16.57%846K
-83.24%1.06M
-83.24%1.06M
Other current assets
10.59%14.75M
-17.59%14.91M
-15.35%15.48M
-40.40%11.81M
-40.40%11.81M
-67.89%13.33M
-58.40%18.1M
-55.77%18.28M
41.19%19.82M
41.19%19.82M
Total current assets
-29.81%184.76M
-28.43%208.54M
-37.73%198.37M
-33.20%233.92M
-33.20%233.92M
18.21%263.22M
20.18%291.38M
15.19%318.54M
27.05%350.16M
27.05%350.16M
Non current assets
Net PPE
-43.80%3.08M
-37.33%3.8M
-32.77%4.45M
-33.82%4.88M
-33.82%4.88M
-30.90%5.48M
-28.70%6.06M
-26.89%6.63M
-22.81%7.38M
-22.81%7.38M
-Gross PPE
-43.80%3.08M
-37.33%3.8M
-32.77%4.45M
-18.36%11.45M
-18.36%11.45M
-30.90%5.48M
-28.70%6.06M
-26.89%6.63M
-10.20%14.02M
-10.20%14.02M
-Accumulated depreciation
----
----
----
1.20%-6.57M
1.20%-6.57M
----
----
----
-9.71%-6.65M
-9.71%-6.65M
Other non current assets
30.57%1.64M
323.26%1.64M
158.36%1.64M
158.29%1.64M
158.29%1.64M
100.64%1.26M
-93.00%387K
-92.49%634K
-96.86%633K
-96.86%633K
Total non current assets
-29.93%4.72M
-15.69%5.44M
-16.08%6.09M
-18.64%6.52M
-18.64%6.52M
-21.28%6.74M
-54.04%6.45M
-58.52%7.26M
-73.03%8.01M
-73.03%8.01M
Total assets
-29.81%189.48M
-28.15%213.98M
-37.24%204.46M
-32.87%240.44M
-32.87%240.44M
16.75%269.96M
16.12%297.83M
10.80%325.8M
17.32%358.17M
17.32%358.17M
Liabilities
Current liabilities
Payables
513.26%5.78M
22.30%2.8M
-44.41%5.03M
12.62%3.12M
12.62%3.12M
15.99%943K
35.01%2.29M
162.94%9.05M
72.99%2.77M
72.99%2.77M
-accounts payable
513.26%5.78M
22.30%2.8M
-44.41%5.03M
12.62%3.12M
12.62%3.12M
15.99%943K
35.01%2.29M
162.94%9.05M
72.99%2.77M
72.99%2.77M
Current accrued expenses
-10.07%50.11M
-3.86%49.81M
16.62%54.85M
15.71%44.88M
15.71%44.88M
-0.01%55.71M
-8.09%51.81M
-19.43%47.03M
-21.53%38.79M
-21.53%38.79M
Current debt and capital lease obligation
14.80%3.67M
14.95%3.55M
15.05%3.43M
15.18%3.31M
15.18%3.31M
15.34%3.2M
17.93%3.08M
20.87%2.98M
24.01%2.87M
24.01%2.87M
-Current capital lease obligation
14.80%3.67M
14.95%3.55M
15.05%3.43M
15.18%3.31M
15.18%3.31M
15.34%3.2M
17.93%3.08M
20.87%2.98M
24.01%2.87M
24.01%2.87M
Other current liabilities
-13.06%1.94M
-16.07%1.47M
-18.55%2.04M
-10.50%1.65M
-10.50%1.65M
-9.50%2.23M
-6.22%1.75M
21.23%2.5M
172.57%1.85M
172.57%1.85M
Current liabilities
-0.94%61.49M
-2.22%57.62M
6.15%65.34M
5.42%69.48M
5.42%69.48M
0.51%62.08M
-5.78%58.93M
-7.21%61.56M
-10.59%65.91M
-10.59%65.91M
Non current liabilities
Long term debt and capital lease obligation
9.30%190.59M
9.77%192.09M
-1.48%173.01M
-1.42%173.71M
-1.42%173.71M
-1.35%174.37M
-1.29%175M
-1.22%175.62M
-1.16%176.2M
-1.16%176.2M
-Long term debt
11.65%190.59M
12.10%191.13M
0.48%171.13M
0.48%170.92M
0.48%170.92M
0.48%170.7M
0.47%170.5M
0.48%170.31M
0.48%170.11M
0.48%170.11M
-Long term capital lease obligation
--0
-78.78%955K
-64.52%1.88M
-54.26%2.79M
-54.26%2.79M
-46.55%3.67M
-40.66%4.5M
-35.92%5.31M
-32.02%6.1M
-32.02%6.1M
Non current deferred liabilities
-44.52%73.5M
-44.62%73.5M
-0.18%132.48M
-0.18%132.48M
-0.18%132.48M
-0.39%132.48M
-0.21%132.72M
-0.21%132.72M
-0.21%132.72M
-0.21%132.72M
Derivative product liabilities
--17.36M
--18.63M
----
----
----
----
----
----
----
----
Other non current liabilities
333.05%6.18M
75.81%4.28M
137.97%2.58M
--978K
--978K
--1.43M
--2.44M
--1.09M
----
----
Total non current liabilities
-6.70%287.63M
-6.98%288.5M
-0.44%308.07M
-0.57%307.17M
-0.57%307.17M
-0.48%308.28M
-0.04%310.15M
-0.44%309.42M
-0.75%308.92M
-0.75%308.92M
Total liabilities
-5.73%349.12M
-6.22%346.12M
0.66%373.41M
0.48%376.64M
0.48%376.64M
-0.31%370.36M
-1.00%369.08M
-1.63%370.97M
-2.64%374.83M
-2.64%374.83M
Shareholders'equity
Share capital
8.33%13K
8.33%13K
0.00%12K
0.00%12K
0.00%12K
50.00%12K
50.00%12K
50.00%12K
50.00%12K
50.00%12K
-common stock
8.33%13K
8.33%13K
0.00%12K
0.00%12K
0.00%12K
50.00%12K
50.00%12K
50.00%12K
50.00%12K
50.00%12K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-6.05%-1.53B
-6.37%-1.5B
-10.62%-1.52B
-10.65%-1.49B
-10.65%-1.49B
-10.71%-1.45B
-11.16%-1.41B
-12.95%-1.38B
-14.02%-1.34B
-14.02%-1.34B
Paid-in capital
2.06%1.37B
2.15%1.37B
1.70%1.36B
1.74%1.35B
1.74%1.35B
15.41%1.35B
16.21%1.34B
17.28%1.33B
20.85%1.33B
20.85%1.33B
Gains losses not affecting retained earnings
70.08%-222K
22.73%-605K
-23.63%-518K
74.76%-161K
74.76%-161K
1.33%-742K
-45.54%-783K
-581.61%-419K
-434.03%-638K
-434.03%-638K
Total stockholders'equity
-59.02%-159.65M
-85.46%-132.14M
-274.01%-168.96M
-717.76%-136.21M
-717.76%-136.21M
28.43%-100.4M
38.76%-71.25M
45.63%-45.17M
79.09%-16.66M
79.09%-16.66M
Total equity
-59.02%-159.65M
-85.46%-132.14M
-274.01%-168.96M
-717.76%-136.21M
-717.76%-136.21M
28.43%-100.4M
38.76%-71.25M
45.63%-45.17M
79.09%-16.66M
79.09%-16.66M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -35.90%133.53M-35.75%152.12M-42.94%148.58M-31.13%191.44M-31.13%191.44M40.39%208.32M38.58%236.77M26.82%260.38M21.59%277.97M21.59%277.97M
-Cash and cash equivalents 66.83%72.83M4.80%84.77M-63.56%30.63M-61.36%52.23M-61.36%52.23M-38.82%43.66M-1.65%80.89M-45.15%84.06M-29.02%135.19M-29.02%135.19M
-Short-term investments -63.14%60.7M-56.79%67.35M-33.11%117.95M-2.50%139.21M-2.50%139.21M113.76%164.66M75.93%155.87M238.72%176.32M274.20%142.78M274.20%142.78M
Receivables -16.20%31.78M17.70%38M-11.70%31.08M-42.74%26.96M-42.74%26.96M38.17%37.92M37.48%32.28M40.85%35.2M109.30%47.09M109.30%47.09M
-Accounts receivable -16.20%31.78M17.70%38M-11.70%31.08M-42.74%26.96M-42.74%26.96M38.17%37.92M37.48%32.28M40.85%35.2M109.30%47.09M109.30%47.09M
Inventory 50.47%4.67M-5.34%3.48M-27.65%2.77M-27.96%3.04M-27.96%3.04M-26.92%3.11M5.82%3.67M-1.21%3.83M2.87%4.22M2.87%4.22M
Restricted cash -93.94%33K-94.36%32K-45.74%459K-37.97%660K-37.97%660K-49.54%545K-50.52%567K-16.57%846K-83.24%1.06M-83.24%1.06M
Other current assets 10.59%14.75M-17.59%14.91M-15.35%15.48M-40.40%11.81M-40.40%11.81M-67.89%13.33M-58.40%18.1M-55.77%18.28M41.19%19.82M41.19%19.82M
Total current assets -29.81%184.76M-28.43%208.54M-37.73%198.37M-33.20%233.92M-33.20%233.92M18.21%263.22M20.18%291.38M15.19%318.54M27.05%350.16M27.05%350.16M
Non current assets
Net PPE -43.80%3.08M-37.33%3.8M-32.77%4.45M-33.82%4.88M-33.82%4.88M-30.90%5.48M-28.70%6.06M-26.89%6.63M-22.81%7.38M-22.81%7.38M
-Gross PPE -43.80%3.08M-37.33%3.8M-32.77%4.45M-18.36%11.45M-18.36%11.45M-30.90%5.48M-28.70%6.06M-26.89%6.63M-10.20%14.02M-10.20%14.02M
-Accumulated depreciation ------------1.20%-6.57M1.20%-6.57M-------------9.71%-6.65M-9.71%-6.65M
Other non current assets 30.57%1.64M323.26%1.64M158.36%1.64M158.29%1.64M158.29%1.64M100.64%1.26M-93.00%387K-92.49%634K-96.86%633K-96.86%633K
Total non current assets -29.93%4.72M-15.69%5.44M-16.08%6.09M-18.64%6.52M-18.64%6.52M-21.28%6.74M-54.04%6.45M-58.52%7.26M-73.03%8.01M-73.03%8.01M
Total assets -29.81%189.48M-28.15%213.98M-37.24%204.46M-32.87%240.44M-32.87%240.44M16.75%269.96M16.12%297.83M10.80%325.8M17.32%358.17M17.32%358.17M
Liabilities
Current liabilities
Payables 513.26%5.78M22.30%2.8M-44.41%5.03M12.62%3.12M12.62%3.12M15.99%943K35.01%2.29M162.94%9.05M72.99%2.77M72.99%2.77M
-accounts payable 513.26%5.78M22.30%2.8M-44.41%5.03M12.62%3.12M12.62%3.12M15.99%943K35.01%2.29M162.94%9.05M72.99%2.77M72.99%2.77M
Current accrued expenses -10.07%50.11M-3.86%49.81M16.62%54.85M15.71%44.88M15.71%44.88M-0.01%55.71M-8.09%51.81M-19.43%47.03M-21.53%38.79M-21.53%38.79M
Current debt and capital lease obligation 14.80%3.67M14.95%3.55M15.05%3.43M15.18%3.31M15.18%3.31M15.34%3.2M17.93%3.08M20.87%2.98M24.01%2.87M24.01%2.87M
-Current capital lease obligation 14.80%3.67M14.95%3.55M15.05%3.43M15.18%3.31M15.18%3.31M15.34%3.2M17.93%3.08M20.87%2.98M24.01%2.87M24.01%2.87M
Other current liabilities -13.06%1.94M-16.07%1.47M-18.55%2.04M-10.50%1.65M-10.50%1.65M-9.50%2.23M-6.22%1.75M21.23%2.5M172.57%1.85M172.57%1.85M
Current liabilities -0.94%61.49M-2.22%57.62M6.15%65.34M5.42%69.48M5.42%69.48M0.51%62.08M-5.78%58.93M-7.21%61.56M-10.59%65.91M-10.59%65.91M
Non current liabilities
Long term debt and capital lease obligation 9.30%190.59M9.77%192.09M-1.48%173.01M-1.42%173.71M-1.42%173.71M-1.35%174.37M-1.29%175M-1.22%175.62M-1.16%176.2M-1.16%176.2M
-Long term debt 11.65%190.59M12.10%191.13M0.48%171.13M0.48%170.92M0.48%170.92M0.48%170.7M0.47%170.5M0.48%170.31M0.48%170.11M0.48%170.11M
-Long term capital lease obligation --0-78.78%955K-64.52%1.88M-54.26%2.79M-54.26%2.79M-46.55%3.67M-40.66%4.5M-35.92%5.31M-32.02%6.1M-32.02%6.1M
Non current deferred liabilities -44.52%73.5M-44.62%73.5M-0.18%132.48M-0.18%132.48M-0.18%132.48M-0.39%132.48M-0.21%132.72M-0.21%132.72M-0.21%132.72M-0.21%132.72M
Derivative product liabilities --17.36M--18.63M--------------------------------
Other non current liabilities 333.05%6.18M75.81%4.28M137.97%2.58M--978K--978K--1.43M--2.44M--1.09M--------
Total non current liabilities -6.70%287.63M-6.98%288.5M-0.44%308.07M-0.57%307.17M-0.57%307.17M-0.48%308.28M-0.04%310.15M-0.44%309.42M-0.75%308.92M-0.75%308.92M
Total liabilities -5.73%349.12M-6.22%346.12M0.66%373.41M0.48%376.64M0.48%376.64M-0.31%370.36M-1.00%369.08M-1.63%370.97M-2.64%374.83M-2.64%374.83M
Shareholders'equity
Share capital 8.33%13K8.33%13K0.00%12K0.00%12K0.00%12K50.00%12K50.00%12K50.00%12K50.00%12K50.00%12K
-common stock 8.33%13K8.33%13K0.00%12K0.00%12K0.00%12K50.00%12K50.00%12K50.00%12K50.00%12K50.00%12K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -6.05%-1.53B-6.37%-1.5B-10.62%-1.52B-10.65%-1.49B-10.65%-1.49B-10.71%-1.45B-11.16%-1.41B-12.95%-1.38B-14.02%-1.34B-14.02%-1.34B
Paid-in capital 2.06%1.37B2.15%1.37B1.70%1.36B1.74%1.35B1.74%1.35B15.41%1.35B16.21%1.34B17.28%1.33B20.85%1.33B20.85%1.33B
Gains losses not affecting retained earnings 70.08%-222K22.73%-605K-23.63%-518K74.76%-161K74.76%-161K1.33%-742K-45.54%-783K-581.61%-419K-434.03%-638K-434.03%-638K
Total stockholders'equity -59.02%-159.65M-85.46%-132.14M-274.01%-168.96M-717.76%-136.21M-717.76%-136.21M28.43%-100.4M38.76%-71.25M45.63%-45.17M79.09%-16.66M79.09%-16.66M
Total equity -59.02%-159.65M-85.46%-132.14M-274.01%-168.96M-717.76%-136.21M-717.76%-136.21M28.43%-100.4M38.76%-71.25M45.63%-45.17M79.09%-16.66M79.09%-16.66M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List